Annual CAPEX
$1.21 B
+$91.00 M+8.14%
December 31, 2023
Summary
- As of February 7, 2025, BMY annual capital expenditures is $1.21 billion, with the most recent change of +$91.00 million (+8.14%) on December 31, 2023.
- During the last 3 years, BMY annual CAPEX has risen by +$456.00 million (+60.56%).
- BMY annual CAPEX is now -0.49% below its all-time high of $1.22 billion, reached on December 31, 2016.
Performance
BMY CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$324.00 M
+$62.00 M+23.66%
September 30, 2024
Summary
- As of February 7, 2025, BMY quarterly capital expenditures is $324.00 million, with the most recent change of +$62.00 million (+23.66%) on September 30, 2024.
- Over the past year, BMY quarterly CAPEX has dropped by -$6.00 million (-1.82%).
- BMY quarterly CAPEX is now -30.77% below its all-time high of $468.00 million, reached on December 31, 2002.
Performance
BMY Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$1.20 B
-$18.00 M-1.48%
September 30, 2024
Summary
- As of February 7, 2025, BMY TTM capital expenditures is $1.20 billion, with the most recent change of -$18.00 million (-1.48%) on September 30, 2024.
- Over the past year, BMY TTM CAPEX has dropped by -$9.00 million (-0.74%).
- BMY TTM CAPEX is now -5.06% below its all-time high of $1.26 billion, reached on March 31, 2017.
Performance
BMY TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
BMY CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.1% | -1.8% | -0.7% |
| 3 y3 years | +60.6% | -1.8% | -0.7% |
| 5 y5 years | +27.1% | -1.8% | -0.7% |
BMY CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.3% | -6.4% | +31.2% | -2.0% | +23.3% |
| 5 y | 5-year | at high | +60.6% | -6.4% | +147.3% | -2.0% | +66.4% |
| alltime | all time | -0.5% | +229.4% | -30.8% | +337.8% | -5.1% | +943.5% |
Bristol-Myers Squibb CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $324.00 M(+23.7%) | $1.20 B(-1.5%) |
| Jun 2024 | - | $262.00 M(-7.7%) | $1.22 B(+0.2%) |
| Mar 2024 | - | $284.00 M(-13.9%) | $1.22 B(+0.5%) |
| Dec 2023 | $1.21 B(+8.1%) | $330.00 M(-3.5%) | $1.21 B(-1.3%) |
| Sep 2023 | - | $342.00 M(+32.0%) | $1.23 B(+8.4%) |
| Jun 2023 | - | $259.00 M(-6.8%) | $1.13 B(-1.1%) |
| Mar 2023 | - | $278.00 M(-19.7%) | $1.14 B(+2.2%) |
| Dec 2022 | $1.12 B(+14.9%) | $346.00 M(+40.1%) | $1.12 B(+2.4%) |
| Sep 2022 | - | $247.00 M(-9.2%) | $1.09 B(-2.1%) |
| Jun 2022 | - | $272.00 M(+7.5%) | $1.11 B(+5.9%) |
| Mar 2022 | - | $253.00 M(-20.9%) | $1.05 B(+8.2%) |
| Dec 2021 | $973.00 M(+29.2%) | $320.00 M(+18.5%) | $973.00 M(+4.0%) |
| Sep 2021 | - | $270.00 M(+28.6%) | $936.00 M(+14.3%) |
| Jun 2021 | - | $210.00 M(+21.4%) | $819.00 M(+10.7%) |
| Mar 2021 | - | $173.00 M(-38.9%) | $740.00 M(-1.7%) |
| Dec 2020 | $753.00 M(-9.9%) | $283.00 M(+85.0%) | $753.00 M(+4.4%) |
| Sep 2020 | - | $153.00 M(+16.8%) | $721.00 M(-4.9%) |
| Jun 2020 | - | $131.00 M(-29.6%) | $758.00 M(-7.3%) |
| Mar 2020 | - | $186.00 M(-25.9%) | $818.00 M(-2.2%) |
| Dec 2019 | $836.00 M(-12.1%) | $251.00 M(+32.1%) | $836.00 M(-4.5%) |
| Sep 2019 | - | $190.00 M(-0.5%) | $875.00 M(-3.7%) |
| Jun 2019 | - | $191.00 M(-6.4%) | $909.00 M(-0.8%) |
| Mar 2019 | - | $204.00 M(-29.7%) | $916.00 M(-3.7%) |
| Dec 2018 | $951.00 M(-9.9%) | $290.00 M(+29.5%) | $951.00 M(+3.9%) |
| Sep 2018 | - | $224.00 M(+13.1%) | $915.00 M(-4.0%) |
| Jun 2018 | - | $198.00 M(-17.2%) | $953.00 M(-5.0%) |
| Mar 2018 | - | $239.00 M(-5.9%) | $1.00 B(-4.9%) |
| Dec 2017 | $1.05 B(-13.2%) | $254.00 M(-3.1%) | $1.05 B(-10.0%) |
| Sep 2017 | - | $262.00 M(+5.6%) | $1.17 B(-6.3%) |
| Jun 2017 | - | $248.00 M(-14.8%) | $1.25 B(-1.0%) |
| Mar 2017 | - | $291.00 M(-21.6%) | $1.26 B(+4.0%) |
| Dec 2016 | $1.22 B(+48.2%) | $371.00 M(+8.8%) | $1.22 B(+7.6%) |
| Sep 2016 | - | $341.00 M(+30.7%) | $1.13 B(+10.5%) |
| Jun 2016 | - | $261.00 M(+7.9%) | $1.02 B(+10.4%) |
| Mar 2016 | - | $242.00 M(-15.1%) | $926.00 M(+12.9%) |
| Dec 2015 | $820.00 M(+55.9%) | $285.00 M(+21.8%) | $820.00 M(+12.9%) |
| Sep 2015 | - | $234.00 M(+41.8%) | $726.00 M(+21.2%) |
| Jun 2015 | - | $165.00 M(+21.3%) | $599.00 M(+10.1%) |
| Mar 2015 | - | $136.00 M(-28.8%) | $544.00 M(+3.4%) |
| Dec 2014 | $526.00 M(-2.0%) | $191.00 M(+78.5%) | $526.00 M(-1.7%) |
| Sep 2014 | - | $107.00 M(-2.7%) | $535.00 M(-3.1%) |
| Jun 2014 | - | $110.00 M(-6.8%) | $552.00 M(+2.2%) |
| Mar 2014 | - | $118.00 M(-41.0%) | $540.00 M(+0.6%) |
| Dec 2013 | $537.00 M(-2.0%) | $200.00 M(+61.3%) | $537.00 M(+4.9%) |
| Sep 2013 | - | $124.00 M(+26.5%) | $512.00 M(-2.5%) |
| Jun 2013 | - | $98.00 M(-14.8%) | $525.00 M(-2.8%) |
| Mar 2013 | - | $115.00 M(-34.3%) | $540.00 M(-1.5%) |
| Dec 2012 | $548.00 M(+49.3%) | $175.00 M(+27.7%) | $548.00 M(+8.1%) |
| Sep 2012 | - | $137.00 M(+21.2%) | $507.00 M(+11.7%) |
| Jun 2012 | - | $113.00 M(-8.1%) | $454.00 M(+9.4%) |
| Mar 2012 | - | $123.00 M(-8.2%) | $415.00 M(+13.1%) |
| Dec 2011 | $367.00 M(-13.4%) | $134.00 M(+59.5%) | $367.00 M(+2.5%) |
| Sep 2011 | - | $84.00 M(+13.5%) | $358.00 M(-1.4%) |
| Jun 2011 | - | $74.00 M(-1.3%) | $363.00 M(-1.9%) |
| Mar 2011 | - | $75.00 M(-40.0%) | $370.00 M(-12.7%) |
| Dec 2010 | $424.00 M(-41.9%) | $125.00 M(+40.4%) | $424.00 M(-14.3%) |
| Sep 2010 | - | $89.00 M(+9.9%) | $495.00 M(-13.9%) |
| Jun 2010 | - | $81.00 M(-37.2%) | $575.00 M(-12.6%) |
| Mar 2010 | - | $129.00 M(-34.2%) | $658.00 M(-9.9%) |
| Dec 2009 | $730.00 M(-22.4%) | $196.00 M(+16.0%) | $730.00 M(-10.9%) |
| Sep 2009 | - | $169.00 M(+3.0%) | $819.00 M(-3.2%) |
| Jun 2009 | - | $164.00 M(-18.4%) | $846.00 M(-5.2%) |
| Mar 2009 | - | $201.00 M(-29.5%) | $892.00 M(-5.2%) |
| Dec 2008 | $941.00 M(+11.6%) | $285.00 M(+45.4%) | $941.00 M(+3.9%) |
| Sep 2008 | - | $196.00 M(-6.7%) | $906.00 M(+1.2%) |
| Jun 2008 | - | $210.00 M(-16.0%) | $895.00 M(+0.4%) |
| Mar 2008 | - | $250.00 M(0.0%) | $891.00 M(+5.7%) |
| Dec 2007 | $843.00 M | $250.00 M(+35.1%) | $843.00 M(+2.9%) |
| Sep 2007 | - | $185.00 M(-10.2%) | $819.00 M(-1.8%) |
| Jun 2007 | - | $206.00 M(+2.0%) | $834.00 M(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $202.00 M(-10.6%) | $793.00 M(0.0%) |
| Dec 2006 | $793.00 M(+3.3%) | $226.00 M(+13.0%) | $793.00 M(+3.0%) |
| Sep 2006 | - | $200.00 M(+21.2%) | $770.00 M(+1.9%) |
| Jun 2006 | - | $165.00 M(-18.3%) | $756.00 M(-4.2%) |
| Mar 2006 | - | $202.00 M(-0.5%) | $789.00 M(+2.7%) |
| Dec 2005 | $768.00 M(-5.1%) | $203.00 M(+9.1%) | $768.00 M(0.0%) |
| Sep 2005 | - | $186.00 M(-6.1%) | $768.00 M(-13.2%) |
| Jun 2005 | - | $198.00 M(+9.4%) | $885.00 M(+7.0%) |
| Mar 2005 | - | $181.00 M(-10.8%) | $827.00 M(+2.2%) |
| Dec 2004 | $809.00 M(-18.3%) | $203.00 M(-33.0%) | $809.00 M(-13.5%) |
| Sep 2004 | - | $303.00 M(+116.4%) | $935.00 M(+6.4%) |
| Jun 2004 | - | $140.00 M(-14.1%) | $879.00 M(-6.5%) |
| Mar 2004 | - | $163.00 M(-50.5%) | $940.00 M(-5.1%) |
| Dec 2003 | $990.00 M(-16.2%) | $329.00 M(+33.2%) | $990.00 M(-12.3%) |
| Sep 2003 | - | $247.00 M(+22.9%) | $1.13 B(+0.9%) |
| Jun 2003 | - | $201.00 M(-5.6%) | $1.12 B(-5.5%) |
| Mar 2003 | - | $213.00 M(-54.5%) | $1.18 B(+0.2%) |
| Dec 2002 | $1.18 B(+15.5%) | $468.00 M(+97.5%) | $1.18 B(+12.6%) |
| Sep 2002 | - | $237.00 M(-10.9%) | $1.05 B(-3.6%) |
| Jun 2002 | - | $266.00 M(+26.1%) | $1.09 B(+2.8%) |
| Mar 2002 | - | $211.00 M(-37.2%) | $1.06 B(+3.5%) |
| Dec 2001 | $1.02 B(+73.7%) | $336.00 M(+21.7%) | $1.02 B(+8.3%) |
| Sep 2001 | - | $276.00 M(+16.9%) | $945.00 M(+17.0%) |
| Jun 2001 | - | $236.00 M(+34.9%) | $808.00 M(+20.1%) |
| Mar 2001 | - | $175.00 M(-32.2%) | $673.00 M(+14.3%) |
| Dec 2000 | $589.00 M(-16.9%) | $258.00 M(+85.6%) | $589.00 M(+0.7%) |
| Sep 2000 | - | $139.00 M(+37.6%) | $585.00 M(-2.8%) |
| Jun 2000 | - | $101.00 M(+11.0%) | $602.00 M(-11.2%) |
| Mar 2000 | - | $91.00 M(-64.2%) | $678.00 M(-4.4%) |
| Dec 1999 | $709.00 M(-10.0%) | $254.00 M(+62.8%) | $709.00 M(+0.4%) |
| Sep 1999 | - | $156.00 M(-11.9%) | $706.00 M(-2.2%) |
| Jun 1999 | - | $177.00 M(+45.1%) | $722.00 M(-4.5%) |
| Mar 1999 | - | $122.00 M(-51.4%) | $756.00 M(-4.1%) |
| Dec 1998 | $788.00 M(+2.7%) | $251.00 M(+45.9%) | $788.00 M(-9.0%) |
| Sep 1998 | - | $172.00 M(-18.5%) | $866.00 M(+0.3%) |
| Jun 1998 | - | $211.00 M(+37.0%) | $863.00 M(+7.9%) |
| Mar 1998 | - | $154.00 M(-53.2%) | $800.00 M(+4.3%) |
| Dec 1997 | $767.00 M(+27.6%) | $329.00 M(+94.7%) | $767.00 M(+17.8%) |
| Sep 1997 | - | $169.00 M(+14.2%) | $651.00 M(+5.0%) |
| Jun 1997 | - | $148.00 M(+22.3%) | $620.00 M(+2.1%) |
| Mar 1997 | - | $121.00 M(-43.2%) | $607.00 M(+1.0%) |
| Dec 1996 | $601.00 M(+17.2%) | $213.00 M(+54.3%) | $601.00 M(+5.6%) |
| Sep 1996 | - | $138.00 M(+2.2%) | $569.00 M(+2.9%) |
| Jun 1996 | - | $135.00 M(+17.4%) | $553.00 M(+2.8%) |
| Mar 1996 | - | $115.00 M(-36.5%) | $538.00 M(+4.9%) |
| Dec 1995 | $513.00 M(-10.5%) | $181.00 M(+48.4%) | $513.00 M(-2.1%) |
| Sep 1995 | - | $122.00 M(+1.7%) | $524.00 M(-3.7%) |
| Jun 1995 | - | $120.00 M(+33.3%) | $544.00 M(-2.2%) |
| Mar 1995 | - | $90.00 M(-53.1%) | $556.00 M(-3.0%) |
| Dec 1994 | $573.00 M(+0.5%) | $192.00 M(+35.2%) | $573.00 M(-3.5%) |
| Sep 1994 | - | $142.00 M(+7.6%) | $594.00 M(+2.2%) |
| Jun 1994 | - | $132.00 M(+23.4%) | $581.00 M(+1.6%) |
| Mar 1994 | - | $107.00 M(-49.8%) | $572.00 M(+0.4%) |
| Dec 1993 | $570.00 M(-11.9%) | $213.00 M(+65.1%) | $570.00 M(+5.0%) |
| Sep 1993 | - | $129.00 M(+4.9%) | $543.00 M(-5.7%) |
| Jun 1993 | - | $123.00 M(+17.1%) | $576.00 M(-8.6%) |
| Mar 1993 | - | $105.00 M(-43.5%) | $630.00 M(-2.6%) |
| Dec 1992 | $647.00 M(+3.0%) | $186.00 M(+14.8%) | $647.00 M(-6.5%) |
| Sep 1992 | - | $162.00 M(-8.5%) | $692.00 M(+2.8%) |
| Jun 1992 | - | $177.00 M(+45.1%) | $673.00 M(+4.7%) |
| Mar 1992 | - | $122.00 M(-47.2%) | $643.00 M(+2.4%) |
| Dec 1991 | $628.00 M(+22.4%) | $231.00 M(+61.5%) | $628.00 M(+11.3%) |
| Sep 1991 | - | $143.00 M(-2.7%) | $564.00 M(+6.8%) |
| Jun 1991 | - | $147.00 M(+37.4%) | $528.00 M(+4.6%) |
| Mar 1991 | - | $107.00 M(-35.9%) | $505.00 M(-1.6%) |
| Dec 1990 | $513.00 M(-7.6%) | $167.00 M(+56.1%) | $513.00 M(+48.3%) |
| Sep 1990 | - | $107.00 M(-13.7%) | $346.00 M(+44.8%) |
| Jun 1990 | - | $124.00 M(+7.8%) | $239.00 M(+107.8%) |
| Mar 1990 | - | $115.00 M | $115.00 M |
| Dec 1989 | $555.00 M | - | - |
FAQ
- What is Bristol-Myers Squibb annual capital expenditures?
- What is the all time high annual CAPEX for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual CAPEX year-on-year change?
- What is Bristol-Myers Squibb quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly CAPEX year-on-year change?
- What is Bristol-Myers Squibb TTM capital expenditures?
- What is the all time high TTM CAPEX for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM CAPEX year-on-year change?
What is Bristol-Myers Squibb annual capital expenditures?
The current annual CAPEX of BMY is $1.21 B
What is the all time high annual CAPEX for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual capital expenditures is $1.22 B
What is Bristol-Myers Squibb annual CAPEX year-on-year change?
Over the past year, BMY annual capital expenditures has changed by +$91.00 M (+8.14%)
What is Bristol-Myers Squibb quarterly capital expenditures?
The current quarterly CAPEX of BMY is $324.00 M
What is the all time high quarterly CAPEX for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly capital expenditures is $468.00 M
What is Bristol-Myers Squibb quarterly CAPEX year-on-year change?
Over the past year, BMY quarterly capital expenditures has changed by -$6.00 M (-1.82%)
What is Bristol-Myers Squibb TTM capital expenditures?
The current TTM CAPEX of BMY is $1.20 B
What is the all time high TTM CAPEX for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM capital expenditures is $1.26 B
What is Bristol-Myers Squibb TTM CAPEX year-on-year change?
Over the past year, BMY TTM capital expenditures has changed by -$9.00 M (-0.74%)